COVID-19, shock séptico refractario y terapia extracorpórea de purificación sanguínea con OXIRIS®

Sepsis is one of the leading causes of death in critically ill patients with COVID-19 and blood purification therapies have a role to immunomodulate the excessive inflammatory response and improve clinical results. One of the devices designed for these therapies is the oXiris® filter, allowing to perform renal replacement therapy combined with selective adsorption of endotoxins and cytokines. We report a 55-year-old male with COVID who developed a septic shock secondary to a sepsis caused by Pseudomona aeruginosa, refractory to the usual management. A veno-venous continuous hemofiltration was started using the oXiris® filter for 48 hours. Subsequently, there was an improvement in clinical perfusion parameters and a reduction in inflammatory markers. The patient was discharged from the intensive care one month later.

Saved in:
Bibliographic Details
Main Authors: Ramírez-Guerrero,Gonzalo, Baghetti-Hernández,Romyna, Godoy-Tello,Cristian, Villagrán-Cortés,Francisco, Torres-Cifuentes,Vicente, Garay-Coloma,Osvaldo
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2022
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872022000200266
Tags: Add Tag
No Tags, Be the first to tag this record!